Synthesis and biological evaluation of thiazolidine-2,4-dione and 2,4-thione derivatives as inhibitors of translation initiation

被引:48
作者
Chen, H
Fan, YH
Natarajan, A
Guo, YH
Iyasere, J
Harbinski, F
Luus, L
Christ, W
Aktas, H
Halperin, JA [1 ]
机构
[1] Harvard Univ, Sch Med, Lab Translat Res, Cambridge, MA 02139 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
translation initiation inhibitors; cancer therapy; thiazolidine-2,4-thione; thiazolidine-2,4-dione;
D O I
10.1016/j.bmcl.2004.08.017
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In an effort to generate novel translation initiation inhibitors for cancer therapy, a series of 2'-benzyloxy-5'-substituted-5-benzylidene-thiazolidine-2,4-thione and dione derivatives was synthesized and evaluated for activity in translation initiation specific assays. Several candidates of the 5-benzylidene-thiazolidine-2,4-diones (3c, 3d, and 3f) and -thiones (2b, 2e, and 2j), inhibit cell growth with low muM GI(50) mediated by inhibition of translation initiation, which involves partial depletion of intracellular Ca2+ stores and strong phosphorylation of eIF2alpha. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5401 / 5405
页数:5
相关论文
共 23 条
  • [1] Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27(KIP1)
    Aktas, H
    Cai, H
    Cooper, GM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (07) : 3850 - 3857
  • [2] Depletion of intracellular Ca2+ stores, phosphorylation of eIF2α, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole
    Aktas, H
    Flückiger, R
    Acosta, JA
    Savage, JM
    Palakurthi, SS
    Halperin, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8280 - 8285
  • [3] Inhibition of translational initiation by activators of the glucose-regulated stress protein and heat shock protein stress response systems - Role of the interferon-inducible double-stranded RNA-activated eukaryotic initiation factor 2 alpha kinase
    Brostrom, CO
    Prostko, CR
    Kaufmann, RJ
    Brostrom, MA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (40) : 24995 - 25002
  • [4] Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones
    Bruno, G
    Costantino, L
    Curinga, C
    Maccari, R
    Monforte, F
    Nicolò, F
    Ottanà, R
    Vigorita, MG
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (04) : 1077 - 1084
  • [5] Translational control: the cancer connection
    Clemens, MJ
    Bommer, UA
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1999, 31 (01) : 1 - 23
  • [6] CLEMENTI E, 1992, J BIOL CHEM, V267, P2164
  • [7] Dua K, 2001, PROTEOMICS, V1, P1191, DOI 10.1002/1615-9861(200110)1:10<1191::AID-PROT1191>3.0.CO
  • [8] 2-8
  • [9] Structure-activity requirements for the antiproliferative effect of troglitazone derivatives mediated by depletion of intracellular calcium
    Fan, YH
    Chen, H
    Natarajan, A
    Guo, YH
    Harbinski, F
    Iyasere, J
    Christ, W
    Aktas, H
    Halperin, JA
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (10) : 2547 - 2550
  • [10] Discovering novel chemotherapeutic drugs for the third millennium
    Garrett, MD
    Workman, P
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (14) : 2010 - 2030